Longhurst, H; Moldovan, D; Bygum, A; Cicardi, M; Huissoon, A; Aygoren-Pursun, E; Grivcheva-Panovska, V; Hagin, D; Steiner, U; Stobiecki, M; Aberer, W; Bethune, C; Faust, SN; Kiani, S; Launay, D; Maurer, M; Rae, W; Reshef, A; Cornpropst, MT; Dobo, SM; VanDyke, S; Murray, S; Collis, PJ; Sheridan, WP; Farkas, H.
Oral Plasma Kallikrein Inhibitor BCX7353 is Safe and Effective as an On-Demand Treatment of Angioedema Attacks in Hereditary Angioedema (HAE) Patients: Results of the ZENITH-1 Trial
J ALLERGY CLIN IMMUN. 2019; 143(2):AB37-AB37.-Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI); FEB 22-25, 2019; San Francisco, CA.
[Oral Communication]
Web of Science